Krishna Instt of Medical Sciences - Krishna Institute of Medical Sciences Share Price

  • 659.2020.21 (3.17%)
  • Volume: 3,98,032
  • Live
  • Last Updated On: 21 May, 2025, 10:38 AM IST
Loading...
Krishna Instt of Medical Sciences - Krishna Institute of Medical Sciences Share Price
  • 659.2020.21 (3.17%)
  • Volume: 3,98,032
Advertisment
Stock Recommendations
  • Potential
    Upside

  • 1 Year
    Target

BUY

Mean Recos by
9 Analysts

0

0

1

4

4

Strong Sell

Sell

Hold

Buy

Strong Buy

Unlock Potential Upside
Stock Reports Plus

/10

Stock Score

View Report
Earnings
Fundamentals
Relative Valuation
Risk
Price Momentum
No Rating (NR)
Negative
Neutral
Positive
Unlock Stock Score

Krishna Instt of Medical Sciences share price insights

  • Company has spent 2.98% of its operating revenues towards interest expenses and 16.46% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

  • Krishna Institute of Medical Sciences Ltd. share price moved up by 3.17% from its previous close of Rs 639.00. Krishna Institute of Medical Sciences Ltd. stock last traded price is 659.20

    Share PriceValue
    Today/Current/Last659.20
    Previous Day639.00638.80

InsightsKrishna Instt of Medical Sciences

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    68.74
    EPS - TTM
    (₹)
    9.61
    MCap
    (₹ Cr.)
    26,431.18
    Sectoral MCap Rank
    7
    PB Ratio
    (x)
    10.57
    Div Yield
    (%)
    0.00
    Face Value
    (₹)
    2.00
    Beta

    Beta

    1 Month-
    3 Months-
    6 Months-
    1 Year-
    3 Years-

    -
    VWAP
    (₹)
    656.81
    52W H/L
    (₹)
    708.00 / 350.00

    Krishna Instt of Medical Sciences Share Price Returns

    1 Day3.17%
    1 Week2.99%
    1 Month-0.23%
    3 Months23.11%
    1 Year70.56%
    3 Years161.23%
    5 YearsN.A.

    ET Stock ScreenersTop Score Companies

    Check whether Krishna Instt of Medical Sciences belongs to analysts' top-rated companies list?

    View Stock Screeners

    Krishna Instt of Medical Sciences Share Recommendations

    Recent Recos

    BUY

    Current

    Mean Recos by 9 Analysts

    Strong
    Sell
    SellHoldBuyStrong
    Buy
    • Target₹3300
    • OrganizationHSBC Asset Management
    • BUY
    • Target₹2200
    • OrganizationPrabhudas Lilladher
    • BUY

    Analyst Trends

    RatingsCurrent1 Week Ago1 Month Ago3 Months Ago
    Strong Buy4555
    Buy4333
    Hold1111
    Sell----
    Strong Sell----
    # Analysts9999

    Krishna Instt of Medical Sciences Financials

    • Insights

      • Employee & Interest Expense

        Company has spent 2.98% of its operating revenues towards interest expenses and 16.46% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
      Quarterly | AnnualMar 2025Dec 2024Sep 2024Jun 2024Mar 2024
      Total Income801.40790.20782.30693.00637.60
      Total Income Growth (%)1.421.0112.898.694.68
      Total Expenses640.70629.90600.20548.00521.13
      Total Expenses Growth (%)1.714.959.535.165.47
      EBIT160.70160.30182.10145.00116.48
      EBIT Growth (%)0.25-11.9725.5924.491.28
      Profit after Tax (PAT)101.8088.70107.4086.6065.47
      PAT Growth (%)14.77-17.4124.0232.27-8.87
      EBIT Margin (%)20.0520.2923.2820.9218.27
      Net Profit Margin (%)12.7011.2313.7312.5010.27
      Basic EPS (₹)2.542.222.6810.828.18
      Quarterly | AnnualMar 2025Dec 2024Sep 2024Jun 2024Mar 2024
      Total Income370.10368.10369.90332.70308.74
      Total Income Growth (%)0.54-0.4911.187.760.80
      Total Expenses241.50259.50266.20247.30238.97
      Total Expenses Growth (%)-6.94-2.527.643.495.10
      EBIT128.60108.60103.7085.4069.78
      EBIT Growth (%)18.424.7321.4322.39-11.59
      Profit after Tax (PAT)93.5076.5072.2060.7048.19
      PAT Growth (%)22.225.9618.9525.95-17.41
      EBIT Margin (%)34.7529.5028.0325.6722.60
      Net Profit Margin (%)25.2620.7819.5218.2415.61
      Basic EPS (₹)2.341.911.807.586.02
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue3,067.002,511.202,223.551,671.091,340.10
      Total Revenue Growth (%)22.1312.9433.0624.7018.73
      Total Expenses2,519.702,051.291,753.471,223.741,061.09
      Total Expenses Growth (%)22.8316.9843.2915.337.38
      Profit after Tax (PAT)384.50310.15336.32332.69201.22
      PAT Growth (%)23.97-7.781.0965.3368.83
      Operating Profit Margin (%)21.0020.2922.7728.0623.42
      Net Profit Margin (%)12.6612.4115.3020.1515.12
      Basic EPS (₹)9.6138.7542.0341.8826.87
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue1,440.801,237.591,155.521,167.55942.30
      Total Revenue Growth (%)16.427.10-1.0323.9018.22
      Total Expenses1,048.50919.42818.19796.55688.04
      Total Expenses Growth (%)14.0412.372.7215.775.76
      Profit after Tax (PAT)302.90235.34252.49278.37188.65
      PAT Growth (%)28.71-6.79-9.3047.5655.77
      Operating Profit Margin (%)30.0126.3329.9032.8328.84
      Net Profit Margin (%)21.8819.2522.3024.3420.22
      Basic EPS (₹)7.5729.4131.5535.0425.20

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets5,736.003,852.022,941.301,907.351,436.15
      Total Assets Growth (%)48.9130.9654.2132.8120.09
      Total Liabilities3,317.201,758.781,003.34496.71559.96
      Total Liabilities Growth (%)88.6175.29102.00-11.30-4.19
      Total Equity2,418.802,093.241,937.961,410.64876.20
      Total Equity Growth (%)15.558.0137.3861.0043.30
      Current Ratio (x)0.831.211.611.831.62
      Total Debt to Equity (x)0.890.570.320.120.33
      Contingent Liabilities0.00555.71458.97103.5742.37
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets3,189.102,396.511,812.071,568.781,213.73
      Total Assets Growth (%)33.0732.2515.5129.2526.77
      Total Liabilities1,021.10530.05181.21191.24306.40
      Total Liabilities Growth (%)92.64192.51-5.24-37.58-8.07
      Total Equity2,168.001,866.451,630.861,377.55907.32
      Total Equity Growth (%)16.1614.4518.3951.8345.45
      Current Ratio (x)0.831.441.982.471.93
      Total Debt to Equity (x)0.330.170.000.010.13
      Contingent Liabilities0.00752.73762.85176.57164.25

      All figures in Rs Cr, unless mentioned otherwise

    • Insights

      • Increase in Cash from Investing

        Company has used Rs 1116.2 cr for investing activities which is an YoY increase of 48.32%. (Source: Consolidated Financials)
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities581.80521.09432.09324.03355.97
      Net Cash used in Investing Activities-1,116.20-752.56-615.60-411.52-354.18
      Net Cash flow from Financing Activities543.10216.7688.3461.009.82
      Net Cash Flow9.10-14.7235.98-26.5011.62
      Closing Cash & Cash Equivalent56.0046.8961.6125.6352.13
      Closing Cash & Cash Equivalent Growth (%)19.43-23.89140.35-50.8328.67
      Total Debt/ CFO (x)3.282.011.230.500.80
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities293.60262.39269.96284.37291.35
      Net Cash used in Investing Activities-626.60-568.65-236.58-375.08-316.60
      Net Cash flow from Financing Activities338.60288.64-15.1475.9825.37
      Net Cash Flow5.60-17.6218.24-14.730.12
      Closing Cash & Cash Equivalent26.1020.4838.1019.8634.59
      Closing Cash & Cash Equivalent Growth (%)27.44-46.2491.85-42.580.34
      Total Debt/ CFO (x)2.411.240.020.060.41

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)17.9816.9620.1423.9823.29
      Return on Capital Employed (%)13.0114.9118.9227.3826.90
      Return on Assets (%)6.708.0511.4317.4414.01
      Interest Coverage Ratio (x)9.0213.9020.6233.4311.73
      Asset Turnover Ratio (x)0.630.740.610.760.77
      Price to Earnings (x)66.6753.1933.5633.22-
      Price to Book (x)11.969.016.747.96-
      EV/EBITDA (x)33.9727.1419.0320.59-
      EBITDA Margin (%)26.8426.1528.6632.4728.65
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)13.9712.6015.4820.2020.79
      Return on Capital Employed (%)14.6714.7120.0026.1726.28
      Return on Assets (%)9.499.8213.9317.7415.54
      Interest Coverage Ratio (x)20.40103.89333.1494.0921.22
      Asset Turnover Ratio (x)0.500.580.670.820.86
      Price to Earnings (x)84.7570.4244.6439.68-
      Price to Book (x)11.808.826.908.02-
      EV/EBITDA (x)55.4744.1629.2325.89-
      EBITDA Margin (%)34.1831.0933.9036.7633.62

    Financial InsightsKrishna Instt of Medical Sciences

    • Income (P&L)
    • Cash Flow
      • Employee & Interest Expense

        Company has spent 2.98% of its operating revenues towards interest expenses and 16.46% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

      • Increase in Cash from Investing

        Company has used Rs 1116.2 cr for investing activities which is an YoY increase of 48.32%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Krishna Instt of Medical Sciences Share Price Forecast

    • Get multiple analysts’ prediction on Krishna Instt of Medical Sciences

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL
    • Get multiple analysts’ prediction on Krishna Instt of Medical Sciences

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL
    • Get multiple analysts’ prediction on Krishna Instt of Medical Sciences

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    Krishna Instt of Medical Sciences Technicals

    • Bullish / Bearish signals for Krishna Instt of Medical Sciences basis selected technical indicators and moving average crossovers.

      5 Day EMA Crossover

      Bearish signal on daily chart

      Appeared on: 20 May 2025

      5D EMA: 642.66

      Last 5 Sell Signals:14 May 2025
      Date7 days Gain/Loss %
      14 May 2025-1.25%
      30 Apr 2025-3.71%
      24 Apr 2025-0.76%
      1 Apr 2025-14.58%
      26 Mar 2025-1.75%

      Average price decline of -2.46% within 7 days of Bearish signal in last 5 years

      Heikin-Ashi Changeover

      Bullish indication on daily chart

      • Prev. Close Price

        643.00

      • LTP

        659.20

      Formed on:20 May 2025

      On daily price chart, Heikin-Ashi candle changed from Red to Green

    • 42%
      Positive Movement since
      1st Jan 2005 on basis
      57%
      Negative Movement since
      1st Jan 2005 on basis
      Exclude
    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic670.88681.82710.57653.07642.13624.32595.57

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR23.7924.8525.55

    Krishna Instt of Medical Sciences Peer Comparison

    Peers InsightsKrishna Instt of Medical Sciences

      Do you find these insights useful?

      • hate it

      • meh

      • love it

      Krishna Instt of Medical Sciences Shareholding Pattern

      • Loading...
        Showing Krishna Instt of Medical Sciences Shareholding as on Mar 2025
        CategoryMar 2025Dec 2024Sep 2024Jun 2024
        Promoters38.8238.8238.8238.82
        Pledge12.0312.1315.3515.78
        FII15.4415.6815.8517.84
        DII31.9532.0532.2932.11
        Mutual Funds25.3525.9925.7725.30
        Others13.7913.4513.0311.23
      • Showing Shareholding as on Mar 2025
        CategoryNo. of SharesPercentage% Change QoQ
        Promoters15,53,31,52038.82 %0.00
        Pledge1,86,92,19012.03 %-0.10
        FII6,18,19,11015.44 %-0.24
        DII12,78,59,40531.95 %-0.09
        MF10,14,42,79625.35 %-0.63
        Others5,51,28,90013.79 %0.34

      Krishna Instt of Medical Sciences MF Ownership

      MF Ownership details are not available.

      Krishna Instt of Medical Sciences Corporate Actions

      • Meeting DateAnnounced onPurposeDetails
        May 12, 2025May 02, 2025Board MeetingAudited Results
        Mar 18, 2025Feb 17, 2025POM-
        Feb 06, 2025Jan 27, 2025Board MeetingQuarterly Results
        Nov 09, 2024Oct 25, 2024Board MeetingQuarterly Results
        Aug 29, 2024Aug 07, 2024AGM-
      • Dividend announcements are not available.

      • All TypesEx-DateRecord DateAnnounced onDetails
        SplitsSep 13, 2024Sep 13, 2024Jun 28, 2024Split: Old FV10.0| New FV:2.0

      About Krishna Instt of Medical Sciences

      Krishna Institute of Medical Sciences Ltd., incorporated in the year 1973, is a Small Cap company (having a market cap of Rs 25,568.88 Crore) operating in Hospitals & Allied Services sector. Krishna Institute of Medical Sciences Ltd. key Products/Revenue Segments include Income from Hospitality, Pharmaceutical Products and Other Operating Revenue for the year ending 31-Mar-2024. Show More

      • Executives

      • Auditors

      • BR

        Bhaskara Rao Bollineni

        Chairman & Managing Director
        AB

        Abhinay Bollineni

        Executive Director & CEO
        AD

        Anitha Dandamudi

        Whole Time Director
        AB

        Adwik Bollineni

        Non Executive Director
        Show More
      • S R Batliboi & Associates LLP

      FAQs about Krishna Instt of Medical Sciences share

      • 1. What is Krishna Instt of Medical Sciences share price and what are the returns for Krishna Instt of Medical Sciences share?
        Krishna Instt of Medical Sciences share price is Rs 659.95 as on 21 May, 2025, 10:31 AM IST. Krishna Instt of Medical Sciences share price is up by 3.28% based on previous share price of Rs 645.1. Krishna Instt of Medical Sciences share price trend:
        • Last 3 Months: Krishna Instt of Medical Sciences share price moved up by 23.25%
        • Last 3 Years: Krishna Instt of Medical Sciences Share price moved up by 161.53%
      • 2. What is 52 week high/low of Krishna Instt of Medical Sciences share price?
        Krishna Instt of Medical Sciences share price saw a 52 week high of Rs 708.00 and 52 week low of Rs 350.00.
      • 3. What are the Krishna Instt of Medical Sciences quarterly results?
        On Consoldiated basis, Krishna Instt of Medical Sciences reported a total income and profit of Rs 801.40 Cr and Rs 101.80 respectively for quarter ending 2025-03-31. Total Income and profit for the year ending 2025-03-31 was Rs 3067.00 Cr and Rs 384.50 Cr.
      • 4. What is the recommendation for Krishna Instt of Medical Sciences - Buy or Sell?
        As per Refinitiv (erstwhile Thomson Reuters), overall mean recommendation by 9 analysts for Krishna Instt of Medical Sciences stock is to Buy. Recommendation breakup is as follows
        • 4 analysts are recommending Strong Buy
        • 4 analysts are recommending to Buy
        • 1 analyst is recommending to Hold
      • 5. What are the returns for Krishna Instt of Medical Sciences share?
        Return Performance of Krishna Instt of Medical Sciences Shares:
        • 1 Week: Krishna Instt of Medical Sciences share price moved up by 3.11%
        • 3 Month: Krishna Instt of Medical Sciences share price moved up by 23.25%
      • 6. Which are the key peers to Krishna Instt of Medical Sciences?
        Within Hospitals & Allied Services sector Krishna Instt of Medical Sciences, Narayana Hrudayalaya Ltd., Aster DM Healthcare Ltd., Global Health Ltd., Rainbow Childrens Medicare Ltd., Jupiter Life Line Hospitals Ltd., Healthcare Global Enterprises Ltd., Indraprastha Medical Corporation Ltd., Artemis Medicare Services Ltd., Yatharth Hospital & Trauma Care Services Ltd. and Fortis Healthcare Ltd. are usually compared together by investors for analysis.
      • 7. Who is the chairman of Krishna Instt of Medical Sciences?
        Bhaskara Rao Bollineni is the Chairman & Managing Director of Krishna Instt of Medical Sciences
      • 8. Who is the Chief Executive Officer of Krishna Instt of Medical Sciences?
        Abhinay Bollineni is the Executive Director & CEO of Krishna Instt of Medical Sciences
      • 9. Who's the owner of Krishna Instt of Medical Sciences?
          • Promoter holding has not changed in last 9 months and holds 38.82 stake as on 31 Mar 2025
          • Domestic Institutional Investors holding have gone down from 32.11 (30 Jun 2024) to 31.95 (31 Mar 2025)
          • Foreign Institutional Investors holding have gone down from 17.84 (30 Jun 2024) to 15.44 (31 Mar 2025)
          • Other investor holding has gone up from 11.23 (30 Jun 2024) to 13.79 (31 Mar 2025)
      • 10. What is the CAGR of Krishna Instt of Medical Sciences?
        The CAGR of Krishna Instt of Medical Sciences is 16.44.
      • 11. What is the PE & PB ratio of Krishna Instt of Medical Sciences?
        The PE ratio of Krishna Instt of Medical Sciences stands at 66.5, while the PB ratio is 10.57.
      • 12. What's the market capitalization of Krishna Instt of Medical Sciences?
        Within the Hospitals & Allied Services sector, Krishna Instt of Medical Sciences stock has a market cap rank of 7. Krishna Instt of Medical Sciences has a market cap of Rs 26,253.12 Cr.
      • 13. How can I quickly analyze Krishna Instt of Medical Sciences stock?
        Krishna Instt of Medical Sciences share can be quickly analyzed on following metrics:
        • Stock's PE is 68.35
        • Price to Book Ratio of 10.57

      Trending in Markets

      Top Gainers As on 10:33 AM | 21 May 2025

      GSK Pharma2,984.00
      197.41 (7.09%)
      JK Tyre370.35
      22.46 (6.46%)
      Data Patterns (India)2,787.60
      148.20 (5.62%)
      Endurance Tech.2,326.40
      110.81 (5.01%)
      Titagarh Wagons932.80
      44.10 (4.97%)

      Top Losers As on 10:32 AM | 21 May 2025

      Dixon Tech15,720.00
      -846.00 (-5.11%)
      KPR Mill1,168.05
      -62.25 (-5.06%)
      Newgen Software1,267.55
      -67.00 (-5.03%)
      Aegis Logistics895.65
      -35.00 (-3.77%)
      Aster DM Health559.90
      -19.50 (-3.37%)

      DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

      DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

      By using this site, you agree to the Terms of Service and Privacy Policy.

      The Economic Times
      OSZAR »